Bio-Rad's D-100 System is a fully automated device, which according to management, utilizes high-performance liquid chromatography (HPLC) technology and facilitates monitoring of long-term control ...

Q2 2025 Management View Norman Schwartz, Chairman & CEO, indicated Bio-Rad delivered solid execution in Q2 2025, with both revenue and operating margin surpassing consensus expectations. Schwartz ...

The lawsuit said that Hercules, California-based Bio-Rad incorporated Caltech's improved multiplexing technology into its QX600 and QX ONE systems — used for cancer research, gene therapy, food ...

Bio-Rad Laboratories, Inc. (BIO) reported the launch of the BioPlex 2200 25-OH Vitamin D kit, which will be used in the company's BioPlex 2200 system. For now, the company has launched the kit ...

Diagnostics firm Bio-Rad Laboratories posted third-quarter profit above Wall Street estimates on Wednesday, helped by a recovery in demand for analytical tools from its biotech clients and steady ...

Bio-Rad's (BIO) D-100 System delivers rapid high-quality HbA1c testing, without sacrificing the ability to detect hemoglobin variants that can interfere with the interpretation of test results.